课题基金 / 基金详情

New analgesics based on µ-conotoxins: structure-based design of helical mimetics

New analgesics based on µ-conotoxins: structure-based design of helical mimetics
基于μ-芋螺毒素的新型镇痛药:基于结构的螺旋模拟物设计
批准号:
DP1094212
负责人:
Prof Raymond Norton
金额:
$24.39万
依托单位:
依托单位国家:
澳大利亚
项目类别:
Discovery Projects
财政年份:
2010
资助国家:
澳大利亚
项目状态:
已结题
起止时间:
2010-01-01 至 2013-12-31

项目摘要

项目成果

Prof Raymond Norton的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Diseases in which voltage-gated sodium channels are implicated are contributors to morbidity and mortality in the Australian population, and this project promises to provide new leads for the future development of drugs to treat such diseases, in particular analgesics for the treatment of chronic pain. The generation of these leads will entail the development of new approaches to mimicking key regions of peptides and proteins in drug-like molecules. This is a highly interdisciplinary project, spanning structural biology, molecular design, medicinal chemistry, molecular biology and electrophysiology, and the training of PhD graduates with such broad experience represents another national benefit of the project.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Australian Sea Anemone Venoms: Bioprospecting & Evolution
  • 批准号:
    LP150100621
  • 项目类别:
    Linkage Projects
  • 资助金额:
    $12.1万
  • 财政年份:
    2015
  • 负责人:
    Prof Raymond Norton
  • 依托单位:
Structure-based and fragment-based approaches to developing new therapeutics
  • 批准号:
    nhmrc : 1059060
  • 项目类别:
    Research Fellowships
  • 资助金额:
    $50.9万
  • 财政年份:
    2014
  • 负责人:
    Prof Raymond Norton
  • 依托单位:
Better drugs and vaccines by design
  • 批准号:
    nhmrc : GNT1059060
  • 项目类别:
    Research Fellowships
  • 资助金额:
    $72.76万
  • 财政年份:
    2014
  • 负责人:
    Prof Raymond Norton
  • 依托单位:
Evolution of a protein fold from toxin to physiological regulator: an endogenous potassium channel blocker in humans
  • 批准号:
    DP1093909
  • 项目类别:
    Discovery Projects
  • 资助金额:
    $23.67万
  • 财政年份:
    2010
  • 负责人:
    Prof Raymond Norton
  • 依托单位:
海外基金